Loss of TMEM65 in mice causes mitochondrial disease mediated by mitochondrial Ca<sup>2</sup>.

Zhang, Yingfan; Parry, Hailey A; Reyes, Laura; Shamoun, Alex; Sun, Junhui; Liu, Chengyu; Springer, Danielle; Noguchi, Audrey et al. · Nat Commun · 2026

basic_science · Level V

Where this comes from

Abstract

Transmembrane protein 65 (TMEM65) depletion in a patient caused severe mitochondrial encephalomyopathy, highlighting its clinical importance. Recent studies show TMEM65 acts as a mitochondrial Na<sup>+</sup>/Ca<sup>2+</sup> exchanger in vitro. Here, we generated conditional Tmem65 knockout mice to define its role in neuromuscular tissues in vivo. Both whole-body and nervous system-specific Tmem65 knockouts exhibited severe growth retardation and seizure-associated sudden death at ~3 weeks, establishing TMEM65 as indispensable for neuronal function. Additionally, skeletal muscle-specific knockout produced adult-onset myopathy preceded by elevated mitochondrial Ca<sup>2+</sup>. Consistently, TMEM65 ablation caused loss of Na<sup>+</sup>-dependent mitochondrial Ca<sup>2+</sup> export. Notably, blocking mitochondrial Ca<sup>2+</sup> entry by mitochondrial calcium uniporter (MCU) knockout rescued the early lethality of whole-body Tmem65 ablation, extending lifespan from ~3 weeks to >1 year. These data reveal an essential physiological role for TMEM65 and suggest that modulating mitochondrial Ca<sup>2+</sup> may offer therapeutic value for TMEM65 misexpression and other mitochondrial diseases associated with Ca<sup>2+</sup> overload.